Searched over 200M research papers
10 papers analyzed
These studies suggest that 5 mg of lisinopril effectively lowers blood pressure in various patient groups, including those with essential hypertension, renovascular hypertension, and elderly patients.
20 papers analyzed
Lisinopril, an angiotensin-converting enzyme (ACE) inhibitor, is widely used to manage hypertension. Understanding the specific impact of a 5 mg dose on blood pressure is crucial for optimizing treatment plans for patients with mild to moderate hypertension.
Several studies have demonstrated the effectiveness of lisinopril in lowering blood pressure. In a study involving Melanesian hypertensive patients, a 5 mg dose of lisinopril significantly reduced systolic blood pressure (SBP) by approximately 24.6 mmHg and diastolic blood pressure (DBP) by 13.3 mmHg after four weeks of treatment. This reduction was comparable to that achieved with amlodipine, another antihypertensive medication.
The dose-response relationship of lisinopril has been well-documented. In a multicenter study, patients receiving 5 mg of lisinopril showed a significant reduction in both supine and erect blood pressure compared to placebo. This study highlighted that higher doses of lisinopril (up to 80 mg) resulted in greater blood pressure reductions, but even the 5 mg dose was effective in achieving clinically meaningful reductions.
Comparative studies have shown that lisinopril is as effective as other antihypertensive agents. For instance, a study comparing lisinopril and amlodipine found no significant difference in blood pressure reduction between the two drugs, with both achieving substantial decreases in SBP and DBP. Another study comparing lisinopril with telmisartan in combination with amlodipine found that while telmisartan had a slightly higher efficacy, lisinopril still provided significant blood pressure control.
Lisinopril is generally well-tolerated, with a safety profile typical of ACE inhibitors. In elderly patients, a starting dose of 5 mg was found to be safe and effective, with no major side effects reported. Additionally, a study on hypertensive children demonstrated that lisinopril was well-tolerated across various doses, including 5 mg, with a consistent dose-response relationship.
Long-term studies have confirmed the safety of lisinopril. In patients with renovascular hypertension, doses starting from 5 mg per day effectively reduced blood pressure without significant adverse effects on renal function or other biochemical parameters. This indicates that lisinopril can be safely used for extended periods in managing hypertension.
A 5 mg dose of lisinopril is effective in significantly lowering blood pressure in patients with mild to moderate hypertension. It is comparable to other antihypertensive agents like amlodipine and telmisartan in efficacy. The drug is well-tolerated with a favorable safety profile, making it a reliable option for long-term hypertension management. Further research may continue to refine its use in specific patient populations, but current evidence supports its effectiveness and safety at this dosage.
Most relevant research papers on this topic